Nine‐ to fourteen‐year follow‐up of implant treatment. Part II: presence of peri‐implant lesions

Roos‐Jansåker, Ann‐Marie; Lindahl, Christel; Renvert, Helena; Renvert, Stefan

doi:10.1111/j.1600-051x.2006.00906.x

Cited by 496 publications

(601 citation statements)

References 26 publications

Supporting

Mentioning

544

Contrasting

Unclassified

Order By: Relevance

“…An analysis of 987 implants followed for 9–14 years demonstrates that signs of mucositis (BoP) are evenly distributed among implants with or without peri‐implantitis. There was actually no difference in the proportion of implants with the absence or presence of bleeding/suppuration in relation to bone loss, bone gain, or bone stability (Roos‐Jansaker, Lindahl, Renvert & Renvert, 2006). Another large cohort study, including 4,591 implants from 2,060 subjects, indicated that minimal bleeding did not correlate with bone loss but multipoint bleeding, profuse bleeding, or suppuration did (French, Cochran & Ofec, 2016).…”

Section: Introductionmentioning

confidence: 99%

How do peri‐implant biologic parameters correspond with implant survival and peri‐implantitis? A critical review

Doornewaard

Jacquet

Cosyn

et al. 2018

Clinical Oral Implants Res

View full text Add to dashboard Cite

ObjectivesThe aim of this critical review was to evaluate whether commonly used biologic diagnostic parameters correspond to implant survival and peri‐implantitis prevalence.Materials and methodsPublications from 2011 to 2017 were selected by an electronic search using the Pubmed database of the US National Library of Medicine. Prospective and retrospective studies with a mean follow‐up time of at least 5 years and reporting prevalence of peri‐implantitis as well as mean bone loss and standard deviation were selected. The correlation between reported prevalence of peri‐implantitis and reported implant survival, mean follow‐up time, mean bone loss, mean probing depth, and mean bleeding on probing was calculated. Mean bone loss and standard deviation were used for estimation of proportion of implants with bone loss exceeding 1, 2, and 3 mm.ResultsFull‐text analysis was performed for 255 papers from 4,173 available ones, and 41 met all the inclusion criteria. The overall mean weighted survival rate was 96.9% (89.9%–100%) and the reported prevalence of peri‐implantitis ranged between 0% and 39.7%, based on 15 different case definitions. The overall weighted bone loss was 1.1 mm based on 8,182 implants and an average mean loading time ranging from 5 to 20 years. No correlation was found between mean bone loss and the reported prevalence of peri‐implantitis. The estimated prevalence of implants with bone loss above 2 mm was 23%. The overall weighted mean probing depth was 3.3 mm, and mean weighted bleeding was 52.2%. Only a weak correlation was found between survival and function time (r = −0.49). There was no relation between the probing depth or bleeding and the mean bone loss, mean follow‐up time, and reported prevalence of peri‐implantitis.ConclusionBiologic parameters mean probing depth and mean bleeding on probing do not correlate with mean bone loss and this irrespective of follow‐up. Case definition for peri‐implantitis varied significantly between studies indicating that an unambiguous definition based on a specified threshold for bone loss is not agreed upon in the literature.

show abstract

Section: Introductionmentioning

confidence: 99%

How do peri‐implant biologic parameters correspond with implant survival and peri‐implantitis? A critical review

Doornewaard

Jacquet

Cosyn

et al. 2018

Clinical Oral Implants Res

View full text Add to dashboard Cite

show abstract

“…The incidence of peri-implant mucositis has been reported to be in the range of 60% of implant recipients and in 48% of implants (Renvert et al, 2007;Roos-Jansaker et al, 2006a). The prevalence of peri-implantitis was found to be around 15, 16 and 28% with respect to the recipients (Fransson et al, 2005;Renvert et al, 2007;Roos-Jansaker et al, 2006a), and 7 and 12% regarding implant sites (Fransson et al, 2005;Roos-Jansaker et al, 2006a). The differences in the prevalence of peri-implantitis may be explained by differing criteria used for the diagnosis of peri-implantitis, as well as variations in maintenance procedures (Fransson et al, 2008;Zitzmann & Berglundh, 2008).…”

Section: Effects Of Chemical Cleaning Agents On Titanium Implant Surfmentioning

confidence: 99%

Surface Aspects of Titanium Dental Implants

Turzó¹

2012

Biotechnology - Molecular Studies and Novel Applications for Improved Quality of Human Life

View full text Add to dashboard Cite

“…13 It has been shown that without systemic support, peri-implantitis is common. 35 Although Ruskin believes implants are superior to endodontically treated teeth due to their ability to resist dental caries, periodontal disease and structural deficiencies, implants with peri-implantitis do not seem to be very successful at resisting complications. 11 The treatment protocol for an implant that has peri-implantitis is to obtain a subgingival bacterial culture and then do a microbiological analysis of the culture.…”

Section: Inmentioning

confidence: 99%

The perceived prognosis of endodontic treatment and implant therapy among dental practitioners

Stockhausen

Aseltine

Matthews

et al. 2011

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, an

View full text Add to dashboard Cite

Nine‐ to fourteen‐year follow‐up of implant treatment. Part II: presence of peri‐implant lesions

Abstract: After 10 years in use without systematic supportive treatment, peri-implant lesions is a common clinical entity adjacent to titanium implants.

Cited by 496 publications

References 26 publications

How do peri‐implant biologic parameters correspond with implant survival and peri‐implantitis? A critical review

How do peri‐implant biologic parameters correspond with implant survival and peri‐implantitis? A critical review

Surface Aspects of Titanium Dental Implants

The perceived prognosis of endodontic treatment and implant therapy among dental practitioners

Contact Info

Product

Resources

About